GR3021114T3 - Treatment of inflammatory bowel disease. - Google Patents
Treatment of inflammatory bowel disease.Info
- Publication number
- GR3021114T3 GR3021114T3 GR960402479T GR960402479T GR3021114T3 GR 3021114 T3 GR3021114 T3 GR 3021114T3 GR 960402479 T GR960402479 T GR 960402479T GR 960402479 T GR960402479 T GR 960402479T GR 3021114 T3 GR3021114 T3 GR 3021114T3
- Authority
- GR
- Greece
- Prior art keywords
- inflammatory bowel
- bowel disease
- treatment
- disease
- carboxypyrazoles
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title abstract 2
- QBPUOAJBMXXBNU-UHFFFAOYSA-N 3-phenyl-1H-pyrazole-5-carboxylic acid Chemical class N1C(C(=O)O)=CC(C=2C=CC=CC=2)=N1 QBPUOAJBMXXBNU-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003854 isothiazoles Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/909,852 US5294630A (en) | 1992-07-07 | 1992-07-07 | Treatment of inflammatory bowel disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3021114T3 true GR3021114T3 (en) | 1996-12-31 |
Family
ID=25427924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960402479T GR3021114T3 (en) | 1992-07-07 | 1996-09-19 | Treatment of inflammatory bowel disease. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5294630A (el) |
| EP (1) | EP0578477B1 (el) |
| JP (1) | JPH06157310A (el) |
| AT (1) | ATE139440T1 (el) |
| AU (1) | AU672977B2 (el) |
| CA (1) | CA2099789A1 (el) |
| DE (1) | DE69303234T2 (el) |
| DK (1) | DK0578477T3 (el) |
| ES (1) | ES2090875T3 (el) |
| GR (1) | GR3021114T3 (el) |
| ZA (1) | ZA934740B (el) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10168095A (ja) * | 1996-12-10 | 1998-06-23 | Cci Corp | 炎症性腸疾患予防および治療剤 |
| US6485938B1 (en) * | 1999-11-16 | 2002-11-26 | Zymogenetics, Inc. | Nucleic acid molecules that encodes human Zven1 |
| US6358939B1 (en) | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| US6989377B2 (en) | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
| US20030118329A1 (en) * | 2001-12-21 | 2003-06-26 | Pere Obrador | Video indexing using high resolution still images |
| EP1558287A4 (en) * | 2002-10-07 | 2009-07-08 | Zymogenetics Inc | USES OF HUMAN ZVEN ANTAGONISTS |
| WO2005072113A2 (en) * | 2004-01-20 | 2005-08-11 | Harty Richard F | Compositions and methods of treatment for inflammatory diseases |
| EP1924603A2 (en) * | 2005-09-13 | 2008-05-28 | Zymogenetics, Inc. | Prok2 antagonists and methods of use |
| ES2276618B1 (es) * | 2005-12-02 | 2008-06-16 | Laboratorios Casen-Fleet, S.L. | Utilizacion rectal de una solucion de cloruro de sodio. |
| JP5199884B2 (ja) * | 2006-12-06 | 2013-05-15 | カルピス株式会社 | 炎症性腸疾患予防治療剤 |
| WO2010042933A2 (en) | 2008-10-10 | 2010-04-15 | Northwestern University | Inhibition and treatment of prostate cancer metastasis |
| JP2017534627A (ja) | 2014-11-06 | 2017-11-24 | ノースウエスタン ユニバーシティＮｏｒｔｈｗｅｓｔｅｒｎ Ｕｎｉｖｅｒｓｉｔｙ | 癌細胞運動性の阻害 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4346094A (en) * | 1980-09-22 | 1982-08-24 | Eli Lilly And Company | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
| US4544752A (en) * | 1980-09-22 | 1985-10-01 | Eli Lilly And Company | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
| US4495195A (en) * | 1982-11-01 | 1985-01-22 | Eli Lilly And Company | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use |
| DE122008000051I1 (de) * | 1990-11-30 | 2009-02-05 | Teijin Ltd | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
-
1992
- 1992-07-07 US US07/909,852 patent/US5294630A/en not_active Expired - Fee Related
-
1993
- 1993-07-01 ZA ZA934740A patent/ZA934740B/xx unknown
- 1993-07-05 CA CA002099789A patent/CA2099789A1/en not_active Abandoned
- 1993-07-05 AU AU41758/93A patent/AU672977B2/en not_active Ceased
- 1993-07-06 DK DK93305298.7T patent/DK0578477T3/da active
- 1993-07-06 ES ES93305298T patent/ES2090875T3/es not_active Expired - Lifetime
- 1993-07-06 JP JP5166779A patent/JPH06157310A/ja active Pending
- 1993-07-06 AT AT93305298T patent/ATE139440T1/de not_active IP Right Cessation
- 1993-07-06 DE DE69303234T patent/DE69303234T2/de not_active Expired - Fee Related
- 1993-07-06 EP EP93305298A patent/EP0578477B1/en not_active Expired - Lifetime
-
1996
- 1996-09-19 GR GR960402479T patent/GR3021114T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06157310A (ja) | 1994-06-03 |
| ES2090875T3 (es) | 1996-10-16 |
| AU672977B2 (en) | 1996-10-24 |
| EP0578477A1 (en) | 1994-01-12 |
| EP0578477B1 (en) | 1996-06-19 |
| ATE139440T1 (de) | 1996-07-15 |
| AU4175893A (en) | 1994-01-13 |
| DK0578477T3 (da) | 1996-07-15 |
| ZA934740B (en) | 1995-01-03 |
| US5294630A (en) | 1994-03-15 |
| DE69303234D1 (de) | 1996-07-25 |
| DE69303234T2 (de) | 1996-11-21 |
| CA2099789A1 (en) | 1994-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW224942B (el) | ||
| NO924461D0 (no) | Dipyridamol for behandling av proliferaktive sykdommer | |
| ATE82121T1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
| SI0654264T1 (en) | Use of venlafaxine or of an aryloxy propanamine compound for the manufacture of a medicament for the treatment of urinary incontinence | |
| GR3023537T3 (en) | Inhibition of thrombin. | |
| MX9205981A (es) | Administracion transdermica de melatonina. | |
| NO951432L (no) | Farmasöytiske preparater | |
| ZA934740B (en) | Treatment of inflammatory bowel disease | |
| ATE150307T1 (de) | Hemmung von seborrhoe und akne | |
| ATE128459T1 (de) | Sulfonanilidderivat und arzneimittel. | |
| NO307689B1 (no) | Anvendelse av et antimikrobielt middel | |
| DE69300321D1 (de) | Behandlung neurodegenerativer Erkrankungen. | |
| EP0328924A3 (en) | Thienotriazolodiazepine compounds and pharmaceutical uses thereof | |
| AU2806692A (en) | Medicament for the treatment of anxiety | |
| ZA931063B (en) | Treatment of glaucoma. | |
| ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
| AU1494395A (en) | The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases | |
| FR2691064B3 (fr) | Nouveau medicament pour le traitement de l'arythmie. | |
| FI933872A0 (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 1,3,4-bensotriazepin-5(4h)-on-derivat | |
| EP0579077A3 (en) | 1,3,4-thiadiazinones for the treatment of cardiovascular diseases | |
| FR2692261B1 (fr) | Procédé de préparation d'un télogène actif. | |
| GB9218223D0 (en) | The use of a compound for the manufacture of a medicament for the treatment of hiv infection | |
| GB9201764D0 (en) | The use of a compound for the manufacture of a medicament for the treatment of hiv infection | |
| RU92015326A (ru) | Средство для лечения конъюнктивита | |
| DK8893D0 (da) | Medicament for treatment or prevention of disease |